ACS Nano | Engineering self-activating polymer nanoenzymes precisely eliminate bacteria within tumor-associated macrophages to enhance immunotherapy based on the blockade of differentiation cluster 47
QQ Academic Group: 1092348845
Detailed
Immunotherapy for colorectal cancer (CRC) is still clinically limited by the extremely immunosuppressive tumor microenvironment. Fusobacterium nucleatum (Fn) selectively colonizes CRC
- Previous: ACS Nano | Phase-separ
- Next: Bioactive Materials |

mxene academic